With the race to develop a COVID-19 vaccine; Stocks for Pre-Clinical Bio-Pharmaceutical companies are definitely one to watch. Kicking off this series w/ @Inovio.
At the time of filming this; Inovio was still in phase 1/3 trials of the COVID-19 vaccine - However, on Oct 3 the FDA put a temporary hold on Inivio's phase 2/3 application so that will definitely play a role in the future direction of this company.
#BTLStockReviews #stockreview #COVID19 #vaccine
